BG105996A - Method of treating eating disorders - Google Patents
Method of treating eating disordersInfo
- Publication number
- BG105996A BG105996A BG105996A BG10599601A BG105996A BG 105996 A BG105996 A BG 105996A BG 105996 A BG105996 A BG 105996A BG 10599601 A BG10599601 A BG 10599601A BG 105996 A BG105996 A BG 105996A
- Authority
- BG
- Bulgaria
- Prior art keywords
- eating disorders
- treating eating
- treating
- nervosa
- snacking
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A compound of formula or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating. 15 claims
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12515099A | 1999-03-17 | 1999-03-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
BG105996A true BG105996A (en) | 2002-06-28 |
BG65170B1 BG65170B1 (en) | 2007-05-31 |
Family
ID=38229636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105996A BG65170B1 (en) | 1999-03-17 | 2001-10-10 | Use of n-substituted derivatives of 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine for the production of a medicine for treating eating disorders |
Country Status (1)
Country | Link |
---|---|
BG (1) | BG65170B1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
JP2675573B2 (en) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | Brain function improver |
IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
2001
- 2001-10-10 BG BG105996A patent/BG65170B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BG65170B1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01009404A (en) | Method of treating eating disorders. | |
GEP20084391B (en) | Pyrazoles and methods of making and using the same | |
CZ305838B6 (en) | N-(2-arylethyl)benzylamines as 5-HT6 receptor antagonists | |
WO2001032652A3 (en) | N-substituted carbamoyloxyalkyl-azolium derivatives | |
MX9605128A (en) | Neurokinine (tachykinine) antagonists. | |
WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
SI0773943T1 (en) | Compounds useful as antiproliferative agents and garft inhibitors | |
AU2003239389A1 (en) | Opioid receptor antagonists | |
GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
MXPA04002495A (en) | Imidazopyridine compounds as 5-ht4. | |
MY138826A (en) | 2,7-substituted indoles | |
WO2000056315A8 (en) | Treatment of pain | |
IL145645A0 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists | |
BG106001A (en) | Method of treating sleep apnoea | |
BG105996A (en) | Method of treating eating disorders | |
NZ504124A (en) | Phenyl-alkyl-imidazoles and use in treating inflammatory disease | |
BG105999A (en) | Treatment of osteoarthritis | |
MXPA04004075A (en) | Compounds and method for the treatment of overactive bladder. | |
NO20063299L (en) | Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-N- (1-azabicyclo [3.3.1] non-4-yl) benzamide hydrochloride hydrate | |
MXPA01009469A (en) | Treatment to lower platelet adhesiveness. | |
MXPA03007309A (en) | Thiophene substituted amine derivatives as glyt-1 inhibitors. | |
MXPA01009468A (en) | Treatment of pulmonary hypertension. | |
BG106000A (en) | Treatment of hiatial hernia | |
HU9401765D0 (en) | Loracarbef hydrochloride c1-c3 alcohol solvates and uses thereof | |
EP1234576A4 (en) | Us0027324for eating disorders |